HK Stock MarketDetailed Quotes

02415 MEDSCI

Watchlist
  • 2.850
  • +0.310+12.20%
Not Open Aug 8 16:08 CST
1.73BMarket Cap28.50P/E (TTM)

About MEDSCI Company

According to Frost & Sullivan's data, based on 2021 registered physician users and average monthly active users, we operate one of the largest online physician platforms in China. As of December 31, 2022, our platform had approximately 2.9 million registered physician users, and our average monthly active users reached about 2.7 million in 2022. Additionally, there is a high percentage of experienced physician users on our Metz Medicine platform. As of December 31, 2021, according to the latest data published by the National Health and Health Commission, the total number of registered physician users with the title of deputy chief physician and above on our Mace Medical platform accounted for 67.1% of the total number of physicians with the title of deputy chief physician and above in China. We believe that a large number of experienced physician users are critical to our business. Due to the relatively high demand for medical research from senior physician users, they are important customers of our physicians' platform solutions and a key source of data for RWS solutions. Furthermore, they are the most important goal of our accurate omni-channel marketing solutions, because their familiarity with certain drugs and medical devices will guide their prescription decisions, and we think their opinions are also important for pharmaceutical and medical device companies to upgrade their medical products. We are able to provide physicians with high-quality academic medical content and drive the growth of the number of users on our Metz Medicine platform. During this track record period, our content production team has built a huge amount of academic medical content on our platform, achieving comprehensive coverage of almost all medical fields. As of December 31, 2022, the content of our Metz Medicine platform covers (including) about 644,000 research results and materials on about 195,000 recent medical developments. We have also collaborated with a number of KOLs to develop academic medical content in the form of online education courses, which mainly include explanations of the latest medical evidence and findings, developments in medical research, and industry guidelines. We believe that providing comprehensive academic medical content helps us create an endogenous physician platform that can independently attract physician users and cultivate user loyalty without relying on traffic from third party sources. The number of registered users increased from about 3.4 million as of December 31, 2020 to about 4.0 million as of December 31, 2021, and further increased to about 4.5 million as of December 31, 2022. The number of registered physician users increased from about 2.3 million as of December 31, 2020 to about 2.6 million as of December 31, 2021, and further increased to about 2.9 million as of December 31, 2022.

Company Profile

Symbol02415
Company NameMEDSCI
ISINKYG5960J1085
Listing DateApr 27, 2023
Issue Price9.10
Shares Offered66.79M share(s)
FoundedJun 22, 2021
Registered AddressCayman Islands
Chairmanfabao zhang
Secretarychunguanxiuyan yang
Audit InstitutionErnst & Young
Company CategoryOverseas registration of Mainland Individuals control
Registered Office89 Nexus Way Camana Bay Grand Cayman, KY1-9009 Cayman Islands
Head Office and Principal Place of Business5/F, Manulife Plaza, 348 Kwun Tong Road, Kowloon, Hong Kong
Fiscal Year Ends12-31
Employees545
MarketHong Kong motherboard
Phone(86)(21)54480588
Emailir@medsci.cn
Business Metz Health Holdings Limited is mainly engaged in providing digital healthcare marketing-related services to pharmaceutical and medical device companies. The company mainly provides omnichannel marketing solutions, physician platform solutions, real-world research solutions, clinical research ancillary services, digital treatment solutions, virtual reality diagnosis, prognostic modeling services, and chronic disease management services. The company mainly operates in domestic and overseas markets.

Company Executives

  • Name
  • Position
  • Salary
  • fabao zhang
  • Chairman of the Board, Executive Director, Chairman of the Nomination Committee
  • --
  • xinmei li
  • CEOs, Executive Director, Remuneration Committee Members, Authorized Representative
  • --
  • jie fan
  • Executive Director
  • --
  • shuai wang
  • VP, Executive Director, Co-CEO
  • --
  • xubo hu
  • Non-executive Directors
  • --
  • shengfeng yan
  • Non-executive Directors
  • --
  • tao liu
  • Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Members
  • --
  • mingyang yu
  • Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Nomination Committee Members
  • --
  • yaokun liu
  • Independent Non-Executive Director, Nomination Committee Members, Audit Committee Members
  • --
  • chun yang
  • VP, Joint Company Secretary
  • --
  • liang cheng
  • Chief Operating Officer
  • --
  • xiaohui yuan
  • Chief Financial Officer
  • --
  • tianpei wang
  • Vice President of R&D
  • --
  • mingai huang
  • Vice President of Medicine
  • --
  • xiuyan guan
  • Joint Company Secretary, Authorized Representative
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg